Cargando…
Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era
BACKGROUND/PURPOSE: Multisystem inflammatory syndrome in children (MIS-C) is a potentially life-threatening condition occurring 2–6 weeks after Coronavirus disease 2019 (COVID-19) in previously healthy children and adolescents, characterized by clinical and laboratory evidence of multiorgan inflamma...
Autores principales: | Valitutti, Francesco, Verde, Alessandra, Pepe, Angela, Sorrentino, Eduardo, Veneruso, Deborah, Ranucci, Giusy, Orlando, Francesca, Mastrominico, Augusto, Grella, Mia Giovanna, Mandato, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028611/ https://www.ncbi.nlm.nih.gov/pubmed/33846690 http://dx.doi.org/10.1016/j.epsc.2021.101838 |
Ejemplares similares
-
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy
por: Pepe, Angela, et al.
Publicado: (2022) -
Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study
por: Giannattasio, Antonietta, et al.
Publicado: (2022) -
Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age
por: Mosca, Caterina, et al.
Publicado: (2023) -
Pediatric Inflammatory Multisystem Syndrome or Multisystem Inflammatory Syndrome in Children: A New Thread in Pandemic Era
por: Arízaga-Ballesteros, Víctor, et al.
Publicado: (2021) -
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis
por: Pepe, Angela, et al.
Publicado: (2023)